Welcome to our dedicated page for Oscar Health news (Ticker: OSCR), a resource for investors and traders seeking the latest updates and insights on Oscar Health stock.
Oscar Health, Inc. (NYSE: OSCR) generates a steady flow of news as a healthcare technology company that combines Individual & Family health insurance plans with a full stack technology platform. Company press releases frequently highlight new market entries, specialized plan designs, and technology-driven member support tools, making OSCR news relevant for investors and observers of the health insurance and digital health sectors.
Much of Oscar’s recent news focuses on the expansion of its affordable, tech-powered health plans across U.S. regions. The company has announced new offerings for individuals, families, and businesses in areas such as Southern Florida, the Tampa Bay area, Orlando and Central Florida, Charlotte and surrounding North Carolina markets, Columbus in Ohio, the Dallas/Fort Worth region in Texas, and multiple counties in Arizona. These announcements detail the availability of Bronze, Silver, Gold, and Redesigned Gold plans, as well as specialized options like HelloMeno menopause plans, condition-focused plans for chronic conditions, Guided Care HMO products, and Spanish-first diabetes plans.
Oscar’s news also covers partnerships and employer-focused initiatives. For example, the Hy-Vee Health with Oscar plan in the Des Moines business community showcases an employer-funded individual market arrangement using an ICHRA structure, combining health coverage, concierge-style care, and lifestyle rewards. In addition, many releases emphasize the role of Oswell, Oscar’s personal health AI agent, and Oscar Care Guides in providing on-demand support and navigation for members.
Investors following OSCR news will also find updates on financial performance and capital structure in the company’s earnings announcements and related Form 8-K filings. These communications include quarterly results, membership metrics, guidance updates, and details on convertible note offerings and exchange agreements. For ongoing insight into how Oscar is expanding its footprint, refining its technology platform, and managing its financial profile, this news feed provides a centralized view of the company’s public disclosures.
Oscar Health, Inc. (NYSE: OSCR) announced the appointment of Mark Bertolini as CEO, effective April 3, 2023. Co-Founder Mario Schlosser transitions to President of Technology, focusing on Oscar's tech platform. Bertolini, previously at Aetna, brings extensive healthcare leadership experience. The company reaffirmed its 2023 guidance and is set to release its Q1 earnings on May 9, 2023. The leadership change aims to enhance growth and profitability, with an emphasis on integrating technology in healthcare.
Oscar Health (NYSE: OSCR) has appointed Dr. Sean Martin, MD, as its new Chief Medical Officer, effective immediately. Dr. Martin, who joined Oscar in 2016, has significant experience in clinical leadership across various functions including affordability and population health. His focus will be on enhancing the quality of care and outcomes for Oscar’s members. His prior roles include Chief Medical Officer at Seremedi and CEO at Medifr. Oscar Health aims to provide accessible healthcare through a technology-driven platform, serving over one million members as of December 31, 2022.
Oscar Health, Inc. (NYSE: OSCR) has renewed its Pharmacy Benefit Manager agreement with CVS Caremark, aiming to enhance cost efficiency for its members. The new agreement, effective from 2023 and extending through 2026, focuses on continued access to CVS Caremark's pharmacy network while allowing Oscar to shape formulary design. Scott Blackley, Chief Transformation Officer, highlighted that CVS Caremark's offer aligns with Oscar's strategic goals of lower costs and enhanced service. This partnership, ongoing since 2012, aims to optimize Oscar's tech-enabled business model and improve member healthcare experience.
Oscar Health, Inc. (NYSE: OSCR) announced that Co-Founder & CEO Mario Schlosser and CFO Sid Sankaran will present at the Cowen 43rd Annual Health Care Conference on
Oscar Health, Inc. (NYSE: OSCR) announced on February 6, 2023, the approval of inducement restricted stock unit awards for 12 new non-executive employees, totaling 832,126 Class A shares. These awards are designed to attract talent under the 2022 Employment Inducement Award Plan and typically vest over one to three years, contingent on continued employment. Oscar Health, founded in 2012, focuses on providing health insurance through a technology-driven platform. The company aims to enhance healthcare accessibility and affordability, having gained over one million members as of December 31, 2022.
Oscar Health, Inc. (NYSE: OSCR) reported a strong financial performance for 2022, with Direct and Assumed Policy Premiums of $6.8 billion, a 99% increase YoY, and earnings of $3.9 billion, a 111% surge. The company improved its Medical Loss Ratio to 85.3% (360 bps improvement) and its Combined Ratio to 105.8% (490 bps improvement). However, it still faced a net loss of $610 million, up $38 million YoY. Looking forward, Oscar anticipates Direct and Assumed Policy Premiums between $6.4 billion and $6.6 billion and projects a Combined Ratio at or below 100% for 2023.
Oscar Health, Inc. (NYSE: OSCR) will release its fourth quarter 2022 and full year 2022 financial results on February 9, 2023, after market close. A conference call will be held at 5:00 PM (ET) to discuss these results. The call can be accessed via a live call or a webcast link, both of which will be available on Oscar's investor relations website following the results announcement. Oscar is known for its technology-driven approach to health insurance and aims to provide affordable health care to its members.
Oscar Health, Inc. (NYSE: OSCR) announced that Co-Founder & CEO Mario Schlosser will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 5:15 PM PT (8:15 PM ET) in San Francisco, CA. Interested parties can listen to a webcast of the presentation on Oscar's investor relations website. Oscar, established in 2012, focuses on making healthcare accessible and affordable, serving over one million members as of September 30, 2022, through a technology-driven approach and a mission to improve member experiences.
Oscar Health, Inc. (NYSE: OSCR) announced it will stop accepting new members in Florida starting December 13 at 12:00 a.m. EST, due to strong Open Enrollment performance. Current members can renew their plans without disruption. This decision follows Oscar's proactive engagement with regulators to manage membership growth and ensure financial stability, as they aim to maintain their target membership of approximately 1 million. Oscar remains committed to the Florida market and will continue to provide coverage throughout 2023 and beyond.
Summary not available.
FAQ
What is the current stock price of Oscar Health (OSCR)?
What is the market cap of Oscar Health (OSCR)?
